Research demonstrates the synthesis of flavone and flavonol analogues as estrogen receptor agonists and COX inhibitors, indicating their potential therapeutic use.
Flavones and flavonols are natural products and privileged structures with diverse bioactivities. Carboranes are considered a three-dimensional bioisosteric surrogate for phenyl rings. Herein, the terminal phenyl group of flavones and flavonols was replaced with carborane, and a series of carborane-containing flavone and flavonol analogues were successfully prepared. These compounds exhibited estrogen receptor (ER) agonist activities. Compound 1 showed an EC₅₀ of 0.87 ± 0.07 μM for ERα and a selectivity of 12.8-fold toward ERβ. These compounds also showed moderate inhibitory activities toward COX-1 and COX-2.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: